Qufora lifts long-term goals despite supply challenges
The medtech firm, which provides solutions for people with chronic bowel disorders, had considerable 2021 topline growth, and is now adjusting its goals for the future.
by christopher due karlsson, translated by daniel pedersen
Qufora, formerly known as MBH-International, has exited 2021 with significant advances on its top line.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
